US Abortion Rates Hold Steady Despite State Restrictions
A new comprehensive report reveals that abortion rates in the United States have remained remarkably stable despite widespread state-level restrictions and bans. The key factors maintaining access appear to be increased interstate travel for procedures and a dramatic surge in telehealth appointments for medication abortions.
Telehealth Revolutionizing Access
The Guttmacher Institute report shows a significant shift toward telehealth services, particularly in states with total abortion bans. Clinicians in states with protective shield laws, such as New York and Massachusetts, are now providing remote consultations and prescriptions to patients living in restrictive states like Texas and Alabama.
"Essentially, these shield laws allow people to get around the effect of their own state's abortion ban," explained Joanne Rosen, professor at the Johns Hopkins School of Public Health. "It makes medication abortion more affordable and accessible while giving providers legal coverage."
Telehealth visits have seen major increases in states with bans, with data scientist Isaac Maddow-Zimet noting this represents the first time researchers have been able to document this shift in near real-time. "It's not surprising, but it is the first time that we've been able to put out specific numbers showing this shift almost in real time," he said.
Interstate Travel Patterns Changing
While travel remains crucial for many seeking abortion care, the patterns have shifted significantly. In 2025, approximately 142,000 people traveled across state lines for abortion care, representing a decline from previous years. Nearly half of these travelers were residents of states with total bans.
The decline in travel is almost entirely among residents of states with total bans, where 12,000 fewer people traveled for abortion last year compared with 2024. However, the total number of people traveling from banned states (62,000) remains more than double the pre-Dobbs decision numbers.
Maddow-Zimet explained the dual trends: "It has become more difficult to travel – more expensive to drive or fly and to procure childcare; and with partial or total bans enacted across swaths of the country, patients frequently have to travel longer distances to access care."
Regulatory Challenges and Legal Battles
The regulatory landscape remains complex and contested. The US Food and Drug Administration is considering imposing restrictions on telehealth prescriptions of mifepristone, despite the medication's proven safety and effectiveness. Several states have filed lawsuits challenging these potential rules.
Meanwhile, shield laws protecting providers are facing legal tests, with Texas bringing civil actions against doctors in New York and California. "We don't yet know what the courts will find," Rosen cautioned about these developing legal challenges.
The report's data comes from clinician records and does not include fully self-managed abortions, meaning the true number of procedures is likely higher than documented. Abortion medication has been FDA-approved up to 10 weeks of pregnancy, though evidence shows effectiveness when used off-label up to and after 12 weeks.
Navigating a Complex Landscape
Patients now face an increasingly complicated patchwork of state laws, requiring what Maddow-Zimet calls "navigational support" to understand how to access reproductive healthcare. "We're in a policy environment where abortion access is incredibly restricted in many states, and because of that, it's really critical that people have multiple routes of access," he emphasized.
The report highlights that while telehealth provides crucial access for many, some patients will always need or prefer in-person care, particularly those later in pregnancy or requiring procedural care. "As long as abortion is banned or restricted in many states, there are always going to be people who need or prefer to travel for in-person care," Maddow-Zimet noted.
The overall abortion numbers show remarkable stability, with a slight increase from 1.124 million to 1.126 million procedures nationally. This stability in the face of significant restrictions demonstrates how both telehealth and travel continue to provide essential pathways to reproductive healthcare across the United States.
